Therapeutic Asset Ratings
1,482 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cyclophosphamide
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
University of Washington
P2/3
BB
(64)
Cyclophosphamide
Precursor B-Cell Acute Lymphoblastic Leukemia
Princess Maxima Center for Pediatric Oncology
P2/3
BB
(64)
Cyclophosphamide
Cutaneous Neuroendocrine Carcinoma
Merck Sharp & Dohme LLC
P2/3
BB
(64)
Cyclophosphamide
T-Cell/Histiocyte Rich Large B Cell Lymphoma
Ruijin Hospital
P2/3
BB
(64)
Cytosin-Arabinosid
Early T Cell Progenitor Acute Lymphoblastic Leukemia
yuejun Liu
P2/3
BB
(64)
Eloxatin
Anal Carcinoma
University of Cincinnati
P2/3
BB
(64)
Eloxatin
Breast
University of Southern California
P2/3
BB
(64)
Eloxatin
Peritoneal Neoplasm
Sun Yat-sen University
P2/3
BB
(64)
Entrectinib
Hematopoietic And Lymphoid System Neoplasm
Cancer Research UK
P2/3
BB
(64)
Epirubicin
Her2-Receptor Negative Breast Cancer
Fudan University
P2/3
BB
(64)
ETOPOSIDE
Acute Leukemia
SWOG Cancer Research Network
P2/3
BB
(64)
ETOPOSIDE
Glioblastoma
Sichuan Honghe Biotechnology Co., Ltd.
P2/3
BB
(64)
FILGRASTIM
Minimal Residual Disease
Masonic Cancer Center, University of Minnesota
P2/3
BB
(64)
FILGRASTIM
Thalassemia
St. Jude Children's Research Hospital
P2/3
BB
(64)
FILGRASTIM
T Lymphoblastic Lymphoma
Children's Oncology Group
P2/3
BB
(64)
FLUOROURACILUM
Neuropathy;Peripheral
Tanta University
P2/3
BB
(64)
Gefetinib
EGFR Gene Mutation
China Medical University Hospital
P2/3
BB
(64)
Gnr-055
Metabolic Disease
AO GENERIUM
P2/3
BB
(64)
Gnr-055
Mucopolysaccharidosis Type 2
AO GENERIUM
P2/3
BB
(64)
HUMAN IMMUNOGLOBULINS
Plasma Cell Myeloma
Monash University
P2/3
BB
(64)
Hycamtin
Fallopian Tube Transitional Cell Carcinoma
National Cancer Institute (NCI)
P2/3
BB
(64)
Hycamtin
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)
P2/3
BB
(64)
Hycamtin
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P2/3
BB
(64)
Ibudilast
Amyotrophic Lateral Sclerosis
MediciNova
P2/3
BB
(64)
Idarubicine
Acute Leukemia
Kura Oncology, Inc.
P2/3
BB
(64)
Showing 226 to 250 of 1,482 assets
Previous
Page 10 of 60
Next